Clinical Trial Update: Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of trastuzumab, bevacizumab, and docetaxel in stage IV metastatic breast cancer completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Bhuvaneswari Ramaswamy | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-12